IT201600092051A1 - Composto medicale per il trattamento di tumori della tiroide - Google Patents

Composto medicale per il trattamento di tumori della tiroide

Info

Publication number
IT201600092051A1
IT201600092051A1 IT102016000092051A IT201600092051A IT201600092051A1 IT 201600092051 A1 IT201600092051 A1 IT 201600092051A1 IT 102016000092051 A IT102016000092051 A IT 102016000092051A IT 201600092051 A IT201600092051 A IT 201600092051A IT 201600092051 A1 IT201600092051 A1 IT 201600092051A1
Authority
IT
Italy
Prior art keywords
treatment
thyroid cancer
medical compound
medical
compound
Prior art date
Application number
IT102016000092051A
Other languages
English (en)
Inventor
Alessandro Antonelli
Vito Coviello
Luca Quattrini
Motta Concettina La
Poupak Fallahi
Silvia Martina Ferrari
Original Assignee
Alessandro Antonelli
Motta Concettina La
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alessandro Antonelli, Motta Concettina La filed Critical Alessandro Antonelli
Priority to IT102016000092051A priority Critical patent/IT201600092051A1/it
Publication of IT201600092051A1 publication Critical patent/IT201600092051A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IT102016000092051A 2016-09-13 2016-09-13 Composto medicale per il trattamento di tumori della tiroide IT201600092051A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102016000092051A IT201600092051A1 (it) 2016-09-13 2016-09-13 Composto medicale per il trattamento di tumori della tiroide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000092051A IT201600092051A1 (it) 2016-09-13 2016-09-13 Composto medicale per il trattamento di tumori della tiroide

Publications (1)

Publication Number Publication Date
IT201600092051A1 true IT201600092051A1 (it) 2018-03-13

Family

ID=58606424

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000092051A IT201600092051A1 (it) 2016-09-13 2016-09-13 Composto medicale per il trattamento di tumori della tiroide

Country Status (1)

Country Link
IT (1) IT201600092051A1 (it)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088097A1 (en) * 2001-04-27 2002-11-07 Vertex Pharmaceuticals Incorporated Triazole-derived kinase inhibitors and uses thereof
WO2002100826A2 (en) * 2001-06-08 2002-12-19 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
WO2004052280A2 (en) * 2002-12-10 2004-06-24 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
WO2007070514A1 (en) * 2005-12-13 2007-06-21 Incyte Corporation Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
EP3050884A1 (en) * 2013-09-26 2016-08-03 Limited Liability Company "National Pharmaceutical Novel chemical compounds (variants) and the use thereof to treat oncological diseases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088097A1 (en) * 2001-04-27 2002-11-07 Vertex Pharmaceuticals Incorporated Triazole-derived kinase inhibitors and uses thereof
WO2002100826A2 (en) * 2001-06-08 2002-12-19 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
WO2004052280A2 (en) * 2002-12-10 2004-06-24 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
WO2007070514A1 (en) * 2005-12-13 2007-06-21 Incyte Corporation Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
EP3050884A1 (en) * 2013-09-26 2016-08-03 Limited Liability Company "National Pharmaceutical Novel chemical compounds (variants) and the use thereof to treat oncological diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LARSEN S D ET AL: "Traceless Solid-Phase Synthesis of 1,2,4-Triazoles Using a Novel Amine Resin", ORGANIC LETTERS , 14(23), 6012-6015 CODEN: ORLEF7; ISSN: 1523-7052,, vol. 3, no. 21, 22 September 2001 (2001-09-22), pages 3341 - 3344, XP002490104, ISSN: 1523-7060, [retrieved on 20010922], DOI: 10.1021/OL016578A *

Similar Documents

Publication Publication Date Title
HK1247202A1 (zh) 用於治療癌症的化合物
IL266847A (en) Cancer treatment methods involving tigit-binding agents
DK3431105T3 (da) Medicinsk sammensætning til behandling af cancer
DK3331915T3 (da) Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere
DK3474841T3 (da) Fremgangsmåder til behandling af ar+-brystkræft
DK3033086T3 (da) Kombinationsterapi til behandling af cancer
DK3277842T3 (da) Fremgangsmåder til at behandle kræftpatienter med farnesyl-transferase-inhibitorer
IL241232B (en) Cancer treatment agents
IL264674B1 (en) Antibodies to siglec7 for cancer treatment
KR20180084772A (ko) 암 치료를 위한 조합 치료법
EP2968348A4 (en) COMPOUNDS FOR THE TREATMENT OF CANCER
SG11202104923YA (en) Pharmaceutical combination for treatment of cancer
DK3474804T4 (da) Medicinsk forbinding
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
DK3622953T3 (da) Kombinationsbehandling af cancer
DK3458610T3 (da) Terapeutisk behandling af brystcancer baseret på c-MAF-status
DK3525774T3 (da) Lasofoxifen behandling af er+ brystcancer
IL259569A (en) Salts of conjugates for cancer treatment
HK1219737A1 (zh) 用於治療癌症的新化合物
SG11202011117VA (en) Treatment of cancer
IL274198A (en) Use of Nox inhibitors to treat cancer
SG10202101501PA (en) PPARγ AGONIST FOR TREATMENT OF BLOOD CANCERS
DK3576740T3 (da) Cancerbehandling
IT201900016760A1 (it) Dispositivo per il trattamento radioterapico di malati oncologici
DK3407909T3 (da) Cancerbehandling